These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24441081)

  • 61. Conformational changes of recombinant monoclonal antibodies by limited proteolytic digestion, stable isotope labeling, and liquid chromatography-mass spectrometry.
    Ponniah G; Nowak C; Kita A; Cheng G; Kori Y; Liu H
    Anal Biochem; 2016 Mar; 497():1-7. PubMed ID: 26747642
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Deamidation and isomerization liability analysis of 131 clinical-stage antibodies.
    Lu X; Nobrega RP; Lynaugh H; Jain T; Barlow K; Boland T; Sivasubramanian A; Vásquez M; Xu Y
    MAbs; 2019 Jan; 11(1):45-57. PubMed ID: 30526254
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development of an efficient LC-MS peptide mapping method using accelerated sample preparation for monoclonal antibodies.
    Jiang P; Li F; Ding J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1137():121895. PubMed ID: 31881514
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Proteomic analysis of the site specificity of glycation and carboxymethylation of ribonuclease.
    Brock JW; Hinton DJ; Cotham WE; Metz TO; Thorpe SR; Baynes JW; Ames JM
    J Proteome Res; 2003; 2(5):506-13. PubMed ID: 14582647
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Detection of oxidized and glycated proteins in clinical samples using mass spectrometry--a user's perspective.
    Thornalley PJ; Rabbani N
    Biochim Biophys Acta; 2014 Feb; 1840(2):818-29. PubMed ID: 23558060
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of IgG1 immunoglobulins and peptide-Fc fusion proteins by limited proteolysis in conjunction with LC-MS.
    Kleemann GR; Beierle J; Nichols AC; Dillon TM; Pipes GD; Bondarenko PV
    Anal Chem; 2008 Mar; 80(6):2001-9. PubMed ID: 18293943
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization of a unique IgG1 mAb CEX profile by limited Lys-C proteolysis/CEX separation coupled with mass spectrometry and structural analysis.
    Kim J; Jones L; Taylor L; Kannan G; Jackson F; Lau H; Latypov RF; Bailey B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(22):1973-81. PubMed ID: 20554483
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An improved trypsin digestion method minimizes digestion-induced modifications on proteins.
    Ren D; Pipes GD; Liu D; Shih LY; Nichols AC; Treuheit MJ; Brems DN; Bondarenko PV
    Anal Biochem; 2009 Sep; 392(1):12-21. PubMed ID: 19457431
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization and comparability of stress-induced oxidation and deamidation on vulnerable sites of etanercept products.
    Huang LJ; Chiang CW; Lee YW; Wang TF; Fong CC; Chen SH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():189-197. PubMed ID: 27237733
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The NISTmAb tryptic peptide spectral library for monoclonal antibody characterization.
    Dong Q; Liang Y; Yan X; Markey SP; Mirokhin YA; Tchekhovskoi DV; Bukhari TH; Stein SE
    MAbs; 2018 Apr; 10(3):354-369. PubMed ID: 29425077
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down study of the effect of harvesting by centrifugation on the post-translational modification profile.
    Reid CQ; Tait A; Baldascini H; Mohindra A; Racher A; Bilsborough S; Smales CM; Hoare M
    Biotechnol Bioeng; 2010 Sep; 107(1):85-95. PubMed ID: 20506289
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multi-Attribute Monitoring of Complex Erythropoetin Beta Glycosylation by GluC Liquid Chromatography-Mass Spectrometry Peptide Mapping.
    Buettner A; Maier M; Bonnington L; Bulau P; Reusch D
    Anal Chem; 2020 Jun; 92(11):7574-7580. PubMed ID: 32426963
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Characterization and quantification of succinimide using peptide mapping under low-pH conditions and hydrophobic interaction chromatography.
    Cao M; Mulagapati SHR; Vemulapalli B; Wang J; Saveliev SV; Urh M; Hunter A; Liu D
    Anal Biochem; 2019 Feb; 566():151-159. PubMed ID: 30503708
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Use of In Vitro Systems To Model In Vivo Degradation of Therapeutic Monoclonal Antibodies.
    Yang N; Tang Q; Hu P; Lewis MJ
    Anal Chem; 2018 Jul; 90(13):7896-7902. PubMed ID: 29860825
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of isomerization and racemization of aspartate in the Asp-Asp motifs of a therapeutic protein.
    Zhang J; Yip H; Katta V
    Anal Biochem; 2011 Mar; 410(2):234-43. PubMed ID: 21130067
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification and measurement of isoaspartic acid formation in the complementarity determining region of a fully human monoclonal antibody.
    Dick LW; Qiu D; Cheng KC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(30):3841-9. PubMed ID: 19819766
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of Recombinant Monoclonal Antibody Charge Variants Using OFFGEL Fractionation, Weak Anion Exchange Chromatography, and Mass Spectrometry.
    Neill A; Nowak C; Patel R; Ponniah G; Gonzalez N; Miano D; Liu H
    Anal Chem; 2015 Jun; 87(12):6204-11. PubMed ID: 25977987
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An Automated and Qualified Platform Method for Site-Specific Succinimide and Deamidation Quantitation Using Low-pH Peptide Mapping.
    Cao M; Xu W; Niu B; Kabundi I; Luo H; Prophet M; Chen W; Liu D; Saveliev SV; Urh M; Wang J
    J Pharm Sci; 2019 Nov; 108(11):3540-3549. PubMed ID: 31374319
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Quantification of in vivo site-specific Asp isomerization and Asn deamidation of mAbs in animal serum using IP-LC-MS.
    Mehl JT; Sleczka BG; Ciccimaro EF; Kozhich AT; Gilbertson DG; Vuppugalla R; Huang CS; Stevens B; Mo J; Deyanova EG; Wang Y; Huang RY; Chen G; Olah TV
    Bioanalysis; 2016 Aug; 8(15):1611-1622. PubMed ID: 27397670
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Optimisation of the use of sliding window deconvolution for comprehensive characterisation of trastuzumab and adalimumab charge variants by native high resolution mass spectrometry.
    Millán-Martín S; Carillo S; Füssl F; Sutton J; Gazis P; Cook K; Scheffler K; Bones J
    Eur J Pharm Biopharm; 2021 Jan; 158():83-95. PubMed ID: 33212184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.